The Efficacy and Safety of Glimepiride in the Management of Type 2 Diabetes in Muslim Patients During Ramadan
Open Access
- 1 February 2005
- journal article
- clinical trial
- Published by American Diabetes Association in Diabetes Care
- Vol. 28 (2), 421-422
- https://doi.org/10.2337/diacare.28.2.421
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fastingDiabetes Research and Clinical Practice, 2002
- Clinical review of glimepirideExpert Opinion on Pharmacotherapy, 2001
- Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ, 2000
- A Placebo‐Controlled, Randomized Study of Glimepiride in Patients with Type 2 Diabetes Mellitus for Whom Diet Therapy is UnsuccessfulThe Journal of Clinical Pharmacology, 1998
- GlimepirideDrugs, 1998
- DIABETIC COMPLICATIONSEndocrinology and Metabolism Clinics of North America, 1996
- Muslims with non-insulin dependent diabetes fasting during Ramadan: treatment with glibenclamide.BMJ, 1993